Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Public ClinicalTrials.gov record NCT03314974. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Myeloablative Allogeneic Hematopoietic Cell Transplantation Using a Related or Unrelated Donor for the Treatment of Hematological Diseases
Study identification
- NCT ID
- NCT03314974
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Masonic Cancer Center, University of Minnesota
- Other
- Enrollment
- 300 participants
Conditions and interventions
Conditions
- Acquired Bone Marrow Failure Syndromes
- Acute Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Biphenotypic/Undifferentiated/Prolymphocytic Leukemias
- Burkitt Lymphoma
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Diffuse Large Cell Non Hodgkins Lymphoma
- Follicular Lymphoma
- High Grade Non-Hodgkin's Lymphoma, Adult
- High Risk Anemia
- Juvenile Myelomonocytic Leukemia
- Lymphoblastic Lymphoma
- Lymphoma
- Lymphoplasmacytic Lymphoma
- MRD Positive Leukemia
- Mantle-Cell Lymphoma
- Marginal Zone B-Cell Lymphoma
- Multiple Myeloma
- Myelodysplasia
- Myelofibrosis
- Myeloproliferative Neoplasms
- Natural Killer Cell Malignancies
- Plasma Cell Leukemia
- Prolymphocytic Leukemia
- Refractory Anemia
- Small Lymphocytic Lymphoma
Interventions
- HSCT with Non-TBI Regimen Biological
- HSCT with TBI Regimen Biological
Biological
Eligibility (public fields only)
- Age range
- Up to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 29, 2018
- Primary completion
- Jun 9, 2026
- Completion
- Jun 9, 2027
- Last update posted
- Jun 23, 2025
2018 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Masonic Cancer Center at University of Minnesota | Minneapolis | Minnesota | 55337 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03314974, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2025 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03314974 live on ClinicalTrials.gov.